Diabetes is reaching epidemic proportions. There are currently about 30 million Americans with diabetes. Every year, about two million additional Americans are diagnosed with diabetes.
“Another 86 million Americans are at high risk and the majority of those folks will be diagnosed with Type 2 Diabetes within the next decade or so,” said Paul Chous, OD.
According to the National Eye Institute, diabetes can lead to eye diseases including diabetic retinopathy, which is one of the leading causes of blindness among working-age adults. The National Eye Institute reports, that 7.7 people age 40 and older have diabetic retinopathy. This number is projected to increase to 11 million by 2030. There is no cure for diabetic retinopathy, and even certain treatments to stave off a loss of visual function aren’t the perfect answer.
“Laser injections don’t always work and can have significant side effects. Plus, most people with diabetes have suboptimal metabolic control,” said Dr. Chous. “Even people with good metabolic control still develop severe diabetic retinopathy.”
Dr. Chous has a private practice specializing in diabetes eye care and education in Tacoma, WA. One strategy he firmly believes in is choosing to be proactive, rather than reactive. Early detection and timely treatment, as well as appropriate follow-up care of diabetic retinopathy, can protect against vision loss.
“Because it is easier to stay well than get well,” he said.
Chous is the Principal Investigator of The Diabetes Visual Function Supplement Study (DiVFuSS), a six month, randomized controlled clinical trial designed to determine if a multi-component nutritional supplement could be of benefit to patients with diabetes.
The landmark findings were published in the British Journal of Ophthalmology.
On April 21, at 7:00 p.m., CST Dr. Chous will be speaking during a webinar about the study. His presentation will contain some information that doctors who have patients with diabetes can incorporate into their practice the next day.